관상동맥 스텐트 시장 : 시장 규모, 점유율 및 성장률, 산업 분석 - 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of coronary stents Market

The global coronary stents market was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, registering a CAGR of 6.54% during 2026-2034. North America dominated the market in 2025 with a 33.55% share, supported by robust healthcare infrastructure, high prevalence of coronary artery diseases (CAD), and frequent product launches backed by regulatory approvals.

Coronary stents are small, tube-shaped devices inserted into coronary arteries to keep them open, primarily used in Percutaneous Coronary Interventions (PCI) to treat conditions like atherosclerosis. The rising global incidence of cardiovascular diseases, technological advancements in stenting procedures, and improved accuracy in PCI operations are driving adoption in both developed and emerging markets.

MARKET DRIVERS

Rising Prevalence of Coronary Heart Disease

The growing prevalence of coronary heart disorders globally is a key market driver. Sedentary lifestyles, stress, and unhealthy eating habits are contributing factors. According to the U.S. CDC, about 5% of adults aged 20+ had CAD in 2023, highlighting a significant patient pool driving demand for stents. Additionally, the aging global population, more prone to CAD, further propels market growth.

Technological Advancements

Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable stents, have enhanced safety and clinical outcomes. Devices like Medtronic's Onyx Frontier DES (FDA approved in 2022) feature improved delivery systems, facilitating complex PCI procedures. Minimally invasive interventions, reduced restenosis rates, and enhanced stent flexibility are increasing adoption among cardiologists worldwide.

MARKET RESTRAINTS

Side Effects and Regulatory Barriers

Complications like arterial damage, allergic reactions, or restenosis can hinder adoption. Strict regulatory approvals also limit product entry in certain regions. Product recalls, such as Atrium Medical's iCast-covered stents in 2022, negatively impact patient trust and market expansion.

MARKET OPPORTUNITIES

Emerging regions present significant growth potential due to rising awareness of cardiovascular diseases, expansion of specialty hospitals, and establishment of catheterization labs. Initiatives like India's public heart health campaigns (2023) and hospital expansions in Australia and India in 2024 demonstrate increasing accessibility and awareness, creating opportunities for stent adoption.

MARKET TRENDS

Continuous innovations in coronary stents, including reducing strut thickness, improving flexibility, and introducing biodegradable polymers, are shaping market growth. Examples include Medinol's EluNIR-PERL DES, FDA approved in 2023, enhancing patient outcomes and procedural efficiency.

SEGMENTATION ANALYSIS

By Stent Type

• Drug-eluting stents (DES) dominate with 76.51% market share in 2026, driven by regulatory approvals, clinical demand, and reduced restenosis rates. Abbott's XIENCE Sierra DES launched in India in 2024 exemplifies this trend.
• Bare metal stents maintain moderate growth due to suitability in high-bleeding-risk patients.
• Bioresorbable stents are expanding due to increasing elderly populations and chronic cardiovascular conditions.
• Covered stents grow via product launches like BIOTRONIK's PK Papyrus in 2019 for emergency perforation treatments.

By Material

• Metal-based stents (stainless steel, cobalt-chromium, platinum-chromium) dominate in 2024 and are projected to continue leading due to efficiency and durability.
• Polymer-based stents (used in bioresorbable devices) are also witnessing growth due to clinical benefits.

By Deployment

• Self-expandable stents accounted for 69.11% share in 2026, offering high clinical efficiency.
• Balloon-expandable stents maintain stable growth, benefiting from technological enhancements and PCI procedures.

By Application

• Chronic Coronary Syndrome (CCS) dominated in 2026 with 89.21% share, reflecting high CAD prevalence.
• Acute Coronary Syndrome (ACS) segment grows due to rising PCI procedures for acute events.

By End-User

• Hospitals & Ambulatory Surgical Centers (ASCs) dominate due to high procedure volumes, advanced infrastructure, and opening of new cardiac care facilities (e.g., Virginia, U.S., 2024).
• Specialty clinics show moderate growth, fueled by increasing cardiologist networks and patient awareness.
• Others (catheterization labs) are steadily expanding.

REGIONAL OUTLOOK

• North America: USD 2.35 billion in 2025, dominating due to advanced infrastructure and high CAD prevalence.
• Europe: Moderate growth; UK USD 0.51 billion and Germany USD 0.64 billion in 2026.
• Asia Pacific: Rapid growth; Japan USD 0.25 billion, China USD 0.39 billion, India USD 0.33 billion in 2026, driven by hospital expansions and new stent launches (Terumo Ultimaster Nagomi in India, 2023).
• Latin America & Middle East & Africa: Steady growth due to rising CAD cases and angioplasty procedures.

COMPETITIVE LANDSCAPE

Key players include Abbott, Medtronic, Boston Scientific, BIOTRONIK, Terumo, MicroPort, B. Braun SE, Stentys, Meril Life Sciences, and Relisys Medical. Strategic acquisitions, regulatory approvals, and clinical trials are the primary growth strategies. Notable developments: Abbott acquiring CSI in 2023 and MicroPort receiving NMPA approval for Firesorb in 2024.

CONCLUSION

The global coronary stents market is projected to grow steadily from USD 7.02 billion in 2025 to USD 12.26 billion by 2034, driven by rising CAD prevalence, technological advancements in stent design, and expansion of healthcare infrastructure worldwide. While procedural risks, regulatory barriers, and product recalls pose challenges, innovations such as drug-eluting, bioresorbable, and self-expandable stents, coupled with emerging regional opportunities, ensure a robust growth trajectory. North America maintains dominance, while Asia Pacific exhibits the highest growth potential, creating significant opportunities for both established and emerging market players.

Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region

By Stent Type * Drug Eluting Stent

• Covered Stent
• Bare Metal Stent
• Bioresorbable Stent
• Others (Dual Therapy Stents)

By Material Type * Metal

• Polymer

By Deployment * Self-expandable

• Balloon-expandable

By Application * Acute Coronary Syndrome (ACS)

• Chronic Coronary Syndrome (CCS)

By End-user * Hospitals & ASCs

• Specialty Clinics
• Others

By Region * North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)

• U.S.
• Canada
• Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Coronary Artery Disease (CAD), by Key countries/sub-region, 2023/2025
• 4.2. Technological Advancements in Coronary Stents
• 4.3. New Product Launches, By Key Players
• 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.5. Impact of COVID-19 on the Market

5. Global Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Stent Type
  • 5.1.1. Drug Eluting Stent
  • 5.1.2. Covered Stent
  • 5.1.3. Bare Metal Stent
  • 5.1.4. Bioresorbable Stent
  • 5.1.5. Others
• 5.2. Market Analysis, Insights and Forecast - By Material Type
  • 5.2.1. Metal
  • 5.2.2. Polymer
• 5.3. Market Analysis, Insights and Forecast - By Deployment
  • 5.3.1. Self-expandable
  • 5.3.2. Balloon-expandable
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Acute Coronary Syndrome (ACS)
  • 5.4.2. Chronic Coronary Syndrome (CCS)
• 5.5. Market Analysis, Insights and Forecast - By End-user
  • 5.5.1. Hospitals & ASCs
  • 5.5.2. Specialty Clinics
  • 5.5.3. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Stent Type
  • 6.1.1. Drug Eluting Stent
  • 6.1.2. Covered Stent
  • 6.1.3. Bare Metal Stent
  • 6.1.4. Bioresorbable Stent
  • 6.1.5. Others
• 6.2. Market Analysis, Insights and Forecast - By Material Type
  • 6.2.1. Metal
  • 6.2.2. Polymer
• 6.3. Market Analysis, Insights and Forecast - By Deployment
  • 6.3.1. Self-expandable
  • 6.3.2. Balloon-expandable
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Acute Coronary Syndrome (ACS)
  • 6.4.2. Chronic Coronary Syndrome (CCS)
• 6.5. Market Analysis, Insights and Forecast - By End-user
  • 6.5.1. Hospitals & ASCs
  • 6.5.2. Specialty Clinics
  • 6.5.3. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Stent Type
  • 7.1.1. Drug Eluting Stent
  • 7.1.2. Covered Stent
  • 7.1.3. Bare Metal Stent
  • 7.1.4. Bioresorbable Stent
  • 7.1.5. Others
• 7.2. Market Analysis, Insights and Forecast - By Material Type
  • 7.2.1. Metal
  • 7.2.2. Polymer
• 7.3. Market Analysis, Insights and Forecast - By Deployment
  • 7.3.1. Self-expandable
  • 7.3.2. Balloon-expandable
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Acute Coronary Syndrome (ACS)
  • 7.4.2. Chronic Coronary Syndrome (CCS)
• 7.5. Market Analysis, Insights and Forecast - By End-user
  • 7.5.1. Hospitals & ASCs
  • 7.5.2. Specialty Clinics
  • 7.5.3. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.6.1. Germany
  • 7.6.2. U.K.
  • 7.6.3. France
  • 7.6.4. Italy
  • 7.6.5. Spain
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia Pacific Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Stent Type
  • 8.1.1. Drug Eluting Stent
  • 8.1.2. Covered Stent
  • 8.1.3. Bare Metal Stent
  • 8.1.4. Bioresorbable Stent
  • 8.1.5. Others
• 8.2. Market Analysis, Insights and Forecast - By Material Type
  • 8.2.1. Metal
  • 8.2.2. Polymer
• 8.3. Market Analysis, Insights and Forecast - By Deployment
  • 8.3.1. Self-expandable
  • 8.3.2. Balloon-expandable
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Acute Coronary Syndrome (ACS)
  • 8.4.2. Chronic Coronary Syndrome (CCS)
• 8.5. Market Analysis, Insights and Forecast - By End-user
  • 8.5.1. Hospitals & ASCs
  • 8.5.2. Specialty Clinics
  • 8.5.3. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Stent Type
  • 9.1.1. Drug Eluting Stent
  • 9.1.2. Covered Stent
  • 9.1.3. Bare Metal Stent
  • 9.1.4. Bioresorbable Stent
  • 9.1.5. Others
• 9.2. Market Analysis, Insights and Forecast - By Material Type
  • 9.2.1. Metal
  • 9.2.2. Polymer
• 9.3. Market Analysis, Insights and Forecast - By Deployment
  • 9.3.1. Self-expandable
  • 9.3.2. Balloon-expandable
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Acute Coronary Syndrome (ACS)
  • 9.4.2. Chronic Coronary Syndrome (CCS)
• 9.5. Market Analysis, Insights and Forecast - By End-user
  • 9.5.1. Hospitals & ASCs
  • 9.5.2. Specialty Clinics
  • 9.5.3. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Stent Type
  • 10.1.1. Drug Eluting Stent
  • 10.1.2. Covered Stent
  • 10.1.3. Bare Metal Stent
  • 10.1.4. Bioresorbable Stent
  • 10.1.5. Others
• 10.2. Market Analysis, Insights and Forecast - By Material Type
  • 10.2.1. Metal
  • 10.2.2. Polymer
• 10.3. Market Analysis, Insights and Forecast - By Deployment
  • 10.3.1. Self-expandable
  • 10.3.2. Balloon-expandable
• 10.4. Market Analysis, Insights and Forecast - By Application
  • 10.4.1. Acute Coronary Syndrome (ACS)
  • 10.4.2. Chronic Coronary Syndrome (CCS)
• 10.5. Market Analysis, Insights and Forecast - By End-user
  • 10.5.1. Hospitals & ASCs
  • 10.5.2. Specialty Clinics
  • 10.5.3. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.6.1. GCC
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products, Financials (based on availability), Recent Developments, Strategies, SWOT, Etc.)
  • 11.2.1. Medtronic
  • 11.2.2. Boston Scientific Corporation
  • 11.2.3. BIOTRONIK SE & Co. KG
  • 11.2.4. Terumo Corporation
  • 11.2.5. Abbott
  • 11.2.6. Relisys Medical Devices Limited.
  • 11.2.7. B. Braun SE
  • 11.2.8. MicroPort Scientific Corporation
  • 11.2.9. Stentys S.A.
  • 11.2.10. Meril Life Sciences Pvt. Ltd.